Baxter International (NYSE:BAX) Stock Rating Lowered by Wall Street Zen

Posted by George Bondi on Oct 12th, 2026

Baxter International (NYSE:BAX – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other analysts also recently issued reports on BAX. UBS Group increased their target price on shares of Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Citigroup reduced their price target on shares of Baxter International from $28.00 to $27.00 and set a “neutral” rating on the stock in a research report on Monday, October 5th. Barclays started coverage on shares of Baxter International in a research note on Wednesday, October 7th. They set an “underweight” rating and a $20.00 price objective for the company. The Goldman Sachs Group increased their price objective on shares of Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. Finally, Weiss Ratings downgraded shares of Baxter International from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $21.73.

View Our Latest Analysis on BAX

Baxter International Price Performance

Shares of NYSE:BAX opened at $24.33 on Friday. The company has a market cap of $12.58 billion, a P/E ratio of -11.75, a P/E/G ratio of 3.68 and a beta of 0.65. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39. Baxter International has a 52 week low of $15.73 and a 52 week high of $30.00. The business has a fifty day simple moving average of $25.23 and a 200-day simple moving average of $21.59.

Baxter International (NYSE:BAX – Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping the consensus estimate of $0.37 by $0.19. The firm had revenue of $2.96 billion during the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. Baxter International’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Equities research analysts forecast that Baxter International will post 2.04 EPS for the current year.

Hedge Funds Weigh In On Baxter International

Several hedge funds and other institutional investors have recently bought and sold shares of BAX. CX Institutional lifted its stake in shares of Baxter International by 2.3% in the third quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock worth $477,000 after acquiring an additional 448 shares in the last quarter. Baird Financial Group Inc. increased its stake in shares of Baxter International by 1.1% in the second quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock worth $953,000 after buying an additional 476 shares during the last quarter. Empirical Finance LLC boosted its stake in Baxter International by 3.5% during the 2nd quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock valued at $387,000 after acquiring an additional 608 shares during the last quarter. CYBER HORNET ETFs LLC grew its holdings in Baxter International by 52.4% during the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 740 shares in the last quarter. Finally, Arizona State Retirement System grew its holdings in Baxter International by 0.8% during the 2nd quarter. Arizona State Retirement System now owns 142,449 shares of the medical instruments supplier’s stock worth $3,037,000 after acquiring an additional 1,111 shares in the last quarter. 90.19% of the stock is owned by institutional investors and hedge funds.

Baxter International Company Profile

(Get Free Report)

Baxter International Inc is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows.